These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
778 related items for PubMed ID: 12794815
1. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations. Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ. Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815 [Abstract] [Full Text] [Related]
2. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Keystone EC, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ. Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476 [Abstract] [Full Text] [Related]
3. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis. Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B. J Rheumatol; 2006 Feb; 33(2):234-43. PubMed ID: 16465653 [Abstract] [Full Text] [Related]
4. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ. N Engl J Med; 1999 Jan 28; 340(4):253-9. PubMed ID: 9920948 [Abstract] [Full Text] [Related]
5. Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience. Moreland LW, Weinblatt ME, Keystone EC, Kremer JM, Martin RW, Schiff MH, Whitmore JB, White BW. J Rheumatol; 2006 May 28; 33(5):854-61. PubMed ID: 16541481 [Abstract] [Full Text] [Related]
6. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Genovese MC, Cohen S, Moreland L, Lium D, Robbins S, Newmark R, Bekker P, 20000223 Study Group. Arthritis Rheum; 2004 May 28; 50(5):1412-9. PubMed ID: 15146410 [Abstract] [Full Text] [Related]
7. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study. Weinblatt ME, Schiff MH, Ruderman EM, Bingham CO, Li J, Louie J, Furst DE. Arthritis Rheum; 2008 Jul 28; 58(7):1921-30. PubMed ID: 18576334 [Abstract] [Full Text] [Related]
8. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, Kremer J, Bear MB, Rich WJ, McCabe D. Arthritis Rheum; 2002 Mar 28; 46(3):614-24. PubMed ID: 11920396 [Abstract] [Full Text] [Related]
9. C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept. Buch MH, Seto Y, Bingham SJ, Bejarano V, Bryer D, White J, Emery P. Arthritis Rheum; 2005 Jan 28; 52(1):42-8. PubMed ID: 15641046 [Abstract] [Full Text] [Related]
10. Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept. Buch MH, Bingham SJ, Bejarano V, Bryer D, White J, Reece R, Quinn M, Emery P. Arthritis Rheum; 2007 Apr 15; 57(3):448-53. PubMed ID: 17394231 [Abstract] [Full Text] [Related]
11. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore JB, White B, Giannini EH, Pediatric Rheumatology Collaborative Study Group. Arthritis Rheum; 2006 Jun 15; 54(6):1987-94. PubMed ID: 16732547 [Abstract] [Full Text] [Related]
12. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial. van der Heijde D, Klareskog L, Singh A, Tornero J, Melo-Gomes J, Codreanu C, Pedersen R, Freundlich B, Fatenejad S. Ann Rheum Dis; 2006 Mar 15; 65(3):328-34. PubMed ID: 16079172 [Abstract] [Full Text] [Related]
13. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, Brown C, Fraser A, Jarret S, Emery P. Arthritis Rheum; 2005 Jan 15; 52(1):27-35. PubMed ID: 15641102 [Abstract] [Full Text] [Related]
14. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators. Ann Rheum Dis; 2008 Feb 15; 67(2):182-8. PubMed ID: 17728331 [Abstract] [Full Text] [Related]
15. Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis. Moreland LW, Cohen SB, Baumgartner SW, Tindall EA, Bulpitt K, Martin R, Weinblatt M, Taborn J, Weaver A, Burge DJ, Schiff MH. J Rheumatol; 2001 Jun 15; 28(6):1238-44. PubMed ID: 11409115 [Abstract] [Full Text] [Related]
16. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ, Hanrahan PS, Kraishi MM, Patel A, Sun G, Bear MB, 990145 Study Group. Ann Rheum Dis; 2004 Sep 15; 63(9):1062-8. PubMed ID: 15082469 [Abstract] [Full Text] [Related]
17. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, Stein CM, Satoi Y, Matsumoto A, Caldwell J, Harris RE, Moreland LW, Hurd E, Yocum D, Stamler DA. Arthritis Rheum; 2002 Aug 15; 46(8):2020-8. PubMed ID: 12209503 [Abstract] [Full Text] [Related]
18. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Davis JC, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, Kivitz A, Fleischmann R, Inman R, Tsuji W, Enbrel Ankylosing Spondylitis Study Group. Arthritis Rheum; 2003 Nov 15; 48(11):3230-6. PubMed ID: 14613288 [Abstract] [Full Text] [Related]
19. Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results. van der Heijde D, Klareskog L, Boers M, Landewé R, Codreanu C, Bolosiu HD, Pedersen R, Fatenejad S, TEMPO Investigators. Ann Rheum Dis; 2005 Nov 15; 64(11):1582-7. PubMed ID: 15860509 [Abstract] [Full Text] [Related]
20. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Grassnickel L, Rudwaleit M, Sieper J, Braun J. Arthritis Rheum; 2003 Jun 15; 48(6):1667-75. PubMed ID: 12794835 [Abstract] [Full Text] [Related] Page: [Next] [New Search]